GREY:IMVIF - Post by User
Comment by
alphaseeking001on Jun 03, 2018 12:31pm
161 Views
Post# 28117186
RE:RE:RE:Imv Presents New Positive Data From Phase 1b/2
RE:RE:RE:Imv Presents New Positive Data From Phase 1b/2 Yes, drug resitance is a commonality for essentially ALL cancers for all therapies so far. One of the primary reasons why they are such a bi%$ to treat. I'm not shocked that they are finding out some mechanisms that some of the tumors are getting around IMV's treatment... they get around ALL cancer therapies. The key here and I agree with you is that these are very good results indeed and will definitly spark further interest in our technology! Remember... these are the ovarian cancers that have already survived and beaten every other therapy thrown at them...! The fact that we are getting results like these in THIS cohort, I feel are very good! Love to here even more feedback from those posters that have more of an immunology background than I do. I may be in the medical field but immunology is not a prime part of my practice.